| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8737574 | Human Immunology | 2018 | 6 Pages |
Abstract
Soluble HLA molecules may have diagnostic value for early-stage NSCLC. Validation studies are currently underway using sera from a lung cancer screening cohort.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Smriti Kanangat, Christopher W. Seder, Melissa R. Pergande, Gabriela C. Lobato, Cristina L. Fhied, Maryam F. Raouf, Michael J. Liptay, Jeffrey A. Borgia,